Literature DB >> 7918368

Activation of bovine liver glutamate dehydrogenase by covalent reaction of adenosine 5'-O-[S-(4-bromo-2,3-dioxobutyl)thiophosphate] with arginine-459 at an ADP regulatory site.

K O Wrzeszczynski1, R F Colman.   

Abstract

Bovine liver glutamate dehydrogenase is an allosteric enzyme which is activated by ADP. The affinity label adenosine 5'-O-[S-(4-bromo-2,3-dioxobutyl)thiophosphate] (AMPSBDB), a new ADP analog featuring a reactive group at a position equivalent to that of the pyrophosphate, reacts with this glutamate dehydrogenase to yield enzyme containing about 0.9 mol/mol of enzyme subunit. The reaction results in a time-dependent irreversible activation of the enzyme. Glutamate dehydrogenase (8.9 microM subunit) modified with 10-60 microM AMPSBDB is about 3.2-fold more active than native enzyme. The modified enzyme is still inhibited by GTP and by high concentrations of NADH, but is no longer activated by ADP. The addition to the reaction mixture of (a) NADH or alpha-ketoglutarate; (b) GTP + NADH; or (c) alpha-ketoglutarate + NADH has little effect on the functional changes produced by AMPSBDB; whereas, the reaction is prevented by ADP. Purification of labeled peptide from proteolytic and chemical digests of [2-3H]AMPSBDB-modified enzyme leads to identification of Arg459 as the target amino acid. We conclude that AMPSBDB functions as an ADP mimic covalently bound to Arg459 within the ADP activator site of the allosteric bovine liver glutamate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918368     DOI: 10.1021/bi00204a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  The structure and allosteric regulation of mammalian glutamate dehydrogenase.

Authors:  Ming Li; Changhong Li; Aron Allen; Charles A Stanley; Thomas J Smith
Journal:  Arch Biochem Biophys       Date:  2011-11-04       Impact factor: 4.013

Review 2.  The structure and allosteric regulation of glutamate dehydrogenase.

Authors:  Ming Li; Changhong Li; Aron Allen; Charles A Stanley; Thomas J Smith
Journal:  Neurochem Int       Date:  2010-11-09       Impact factor: 3.921

3.  Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations.

Authors:  Jie Fang; Betty Y L Hsu; Courtney M MacMullen; Mortimer Poncz; Thomas J Smith; Charles A Stanley
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

4.  Mitochondrial dysfunctions during aging: vitamin E deficiency or caloric restriction--two different ways of modulating stress.

Authors:  Tatiana Armeni; Giovanni Principato; José L Quiles; Carlo Pieri; Stefano Bompadre; Maurizio Battino
Journal:  J Bioenerg Biomembr       Date:  2003-04       Impact factor: 2.945

5.  A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3A.

Authors:  Su H Hung; Andy H Liu; Robin A Pixley; Penelope Francis; LaTeeka D Williams; Christopher M Matsko; Karine D Barnes; Sharmila Sivendran; Roberta F Colman; Robert W Colman
Journal:  Bioorg Chem       Date:  2008-04-03       Impact factor: 5.275

Review 6.  Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia.

Authors:  Suresh Chandran; Fabian Yap; Khalid Hussain
Journal:  World J Diabetes       Date:  2014-10-15

7.  Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase.

Authors:  Amanda J Heslegrave; Ritika R Kapoor; Simon Eaton; Bernadette Chadefaux; Teoman Akcay; Enver Simsek; Sarah E Flanagan; Sian Ellard; Khalid Hussain
Journal:  Orphanet J Rare Dis       Date:  2012-05-14       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.